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Objective: To describe the prevalence of congenital anophthalmia and microphthalmia in 
Hospital Universitario La Paz, and to identify associated risk factors and evaluate cosmetic 
results in treated and nontreated patients.
Methods: A retrospective, descriptive, cross-sectional study of patients treated with orbital 
expanding techniques (cases) and nontreated patients (controls) was carried out as a comparative 
case series study. A total of 36 patients with unilateral or bilateral anophthalmia or microphthal-
mia as main diagnosis were included; 52 epidemiological and management variables for each 
patient were analyzed. The study evaluated orbital growth and facial symmetry.
Results: The overall cosmetic result in the study’s group of patients was satisfactory: 66.7% 
showed good or very good orbital growth, and 75% showed good or very good facial symmetry. 
Controls had better cosmetic outcome but showed more cataracts (P = 0.05), inferior colobomas 
(P = 0.026), and family history (P = 0.056) than the cases. Controls also showed significantly 
better orbital growth (P = 0.042) and facial symmetry (P = 0.014) than the cases.
Conclusion: This study suggests that the mere presence of a globe (controls) still provides 
better orbitofacial development than the artificial stimulation (cases) currently available for 
patients with congenital anophthalmia and microphthalmia, who receive internal and external 
orbital rehabilitation.
Keywords: cosmetic outcome, orbital rehabilitation, ocular malformation, congenital cataract, 
persistent fetal vasculature
Introduction
Congenital anophthalmia and microphthalmia are rare diseases that cause deficient 
orbitofacial growth and impaired visual capability. Congenital anophthalmia is the 
complete absence of the eye due to deficient formation of the optic vesicle during 
early phases of gestation, while microphthalmia refers to the presence of a hypo-
plastic or rudimentary eye at birth. Ocular abnormalities in the development of the 
eye and its adnexal tissues include a wide range of malformations (  anophthalmia, 
synophthalmia or cyclopia, congenital cystic eye, cystic microphthalmia, and 
microphthalmia with cystic teratoma), depending on embryonic age at onset of the 
disease.1–7 Microphthalmia may also manifest as a focal ocular malformation, such 
as congenital cataract or persistent fetal vasculature (PFV), instead of a generalized 
defect of ocular development.
The prevalence of anophthalmia and microphthalmia has been estimated 
at 0.2–3.0 per 10,000 births.1–4,6,8 This severely limits the number of patients 
included in studies and makes it very difficult to find reliable epidemiological data. Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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Cases   associated to other congenital systemic abnormali-
ties have been reported, and both conditions occur in many 
syndromes; for example, Fraser, Fryns, Waardenburg, or 
Matthew-Wood.9–14
A number of possible risk factors have been studied 
without apparent associations being found: maternal and ges-
tational variables, patient characteristics, genetic alterations, 
and environmental factors or drugs during the gestational 
period.1,2,7,16–19
The absence of a normal-sized globe not only means 
orbital cavity and soft tissue growth retardation, but also 
leads to hemifacial microsomia affecting the development 
of the maxilla, maxillary sinus, and mandible.
Typically, severe congenital unilateral   microphthalmia 
or anophthalmia produces bony orbital hypoplasia, 
microblepharon, and facial asymmetry due to hemifacial 
  microsomia. In bilateral cases, the typical features are sunken 
orbits and midfacial hypoplasia.1–4,6
The diagnosis of anophthalmia or microphthalmia is 
clinical, obtained by ophthalmological examination dem-
onstrating the complete absence of the globe or decreased 
ocular size relative to the contralateral eye. Once a diagnosis 
has been established, both ocular and systemic imaging tests 
(ultrasound, computed tomography [CT], and magnetic 
resonance imaging [MRI]) should be performed to rule out 
neurological, renal, cardiac, or other associations.20
Treatment of microphthalmia depends on its severity 
and the visual potential of the affected eye, depending on 
etiology (eg, congenital cataract or PFV). Patients with 
mild microphthalmia are treated (eg, cataract surgery) for 
conditions that may arise, but are normally only subject 
to regular follow-up of orbitofacial growth stimulated 
by the presence of the globe (ie, “natural” stimulation), 
regardless of visual prognosis, unless this “natural stimula-
tion” should prove to be insufficient. Patients with severe 
microphthalmia or anophthalmia, without potential vision, 
undergo early orbital rehabilitation with “artificial” stimu-
lation of orbitofacial growth. Many clinicians begin with 
an external orbital conformer, useful per se, and to create a 
suitable access for a subsequent internal orbital conformer, 
if necessary.
Several techniques and materials (endogenous and 
exogenous) are used to expand orbital volume: serial 
acrylic conformers for conjunctival sac, conventional 
spherical orbital implants, mucous grafts, dermafat, 
bone and muscle grafts, inflatable balloon devices, and 
hemispherical and spherical self-inflating hydrophilic 
(hydrogel) expanders.4–7,21–25
Materials and methods
The objectives of this study were to:
1.  Describe the prevalence of congenital anophthalmia and 
microphthalmia treated at Hospital Universitario La Paz;
2.  Identify risk factors associated with congenital anophthal-
mia and microphthalmia; and
3.  Evaluate cosmetic results in patients treated with orbital 
expanding procedures (cases) and nontreated patients 
(controls).
From the admission date of the first patient in April 1993 
until June 2007, a total of 36 patients from the Paediatric 
Ophthalmology Department, Hospital Universitario La Paz, 
were included in the study. The inclusion criterion was uni-
lateral or bilateral anophthalmia or microphthalmia as the 
initial diagnosis (Table 1).
The sample size (n = 36) in the present study refers 
strictly to patients and not to the total number of affected 
eyes (n = 50). In patients where both eyes were affected, focus 
was on the most affected eye, susceptible to interventional 
procedures, in order to avoid data sampling bias (Figure 1).
In spite of the different geographic origins of these 
  children, minimum follow-up was 6 months (mean follow-up 
was 76.5 ± 57.8 months).
A total of 52 epidemiological and management variables 
were collected for each patient:
•	 Epidemiological variables (Table 2): current age, 
follow-up time, gender, chief complaint, unilateral/
bilateral, left/right eye (when unilateral), diagnosis, 
gestational anomalies, plurality (singleton, multiple), 
delivery (vaginal, forceps assisted, cesarean), parity, 
parity order, geographical origin, maternal age, mater-
nal race/ethnicity, maternal educational level (,12 or 
.12 years at an educational institution; this variable 
was considered as a sociocultural indicator: ,12 years, 
low level; .12 years, high level), ultrasound diagnosis, 
MRI diagnosis, CT diagnosis, positive TORCH serology, 
positive hepatitis serology, genetic anomalies, diagno-
sis group (mild = mild and moderate microphthalmia; 
severe = severe microphthalmia and anophthalmia), 
coloboma, PFV , cataract, neurological anomalies, sys-
temic anomalies, family history, and potential vision.
•	 Management variables (Table 3): retinal detachment 
surgery, cataract surgery, external orbital conformer, 
canthotomy, tarsorrhaphy, conjunctival sac reconstruc-
tion, enucleation, internal orbital conformation, oral 
mucous membrane graft, calvarial bone graft, dermafat 
graft, self-inflating hydrophilic expanders, total number 
of surgeries, useful visual acuity (VA), orbital growth, Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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facial   symmetry, external prosthesis mobility, internal 
prosthesis mobility, implant infection, internal prosthesis 
exposure/extrusion, eyelid ptosis, contralateral eye 
pathology (when unilateral).
Variables such as orbital growth, facial symmetry and 
external or internal prosthesis mobility (Table 4) were evalu-
ated by two independent observers in all patients (except 
one) and classified into four categories (very poor, poor, 
good, and very good). They were therefore considered semi-
quantitative variables.
The study population was then divided into two groups 
according to the variable “potential vision,” which deter-
mined the surgical approach. Those patients with potential 
vision did not undergo orbital expansion treatment and were 
just clinically observed, in order to monitor orbitofacial and 
ocular development (functional, but not cosmetic, surgical 
procedures were permitted, eg, cataract surgery). These 
patients were considered “controls” (n = 14).
Patients without potential vision (“cases,” n = 22) 
underwent external and/or internal expansion surgery, 
according to degree of severity. The cases were then divided 
into less severe (microphthalmia) and more severe (severe 
microphthalmia and anophthalmia).
Eyes with an axial length of 15–17 mm were classified 
as having mild microphthalmia, 13–15 mm as moderate, and 
less than 13 mm as severe (Figure 1). Anophthalmia was 
considered the absence of a globe on imaging techniques.
Following the study protocol, orbital rehabilitation in 
the more severe cases began in the first 3 months of life, 
with primary external orbital conformers, except in two 
patients who needed a secondary internal orbital conformer. 
Obviously, those patients who needed primary internal orbital 
conformers (six cases with anophthalmia) were also treated 
with external conformers at the same time.
The study’s purpose was to determine whether there were 
any epidemiological or cosmetically significant differences 
between groups with “natural” (controls) or “artificial” orbital 
growth stimulation (cases). Because of the heterogeneity of 
the groups and the retrospective nature of the study, this was 
not a case-control study but rather a case series study.
A Microsoft Excel database was created, and SPSS 
  Statistics (v 11.0; IBM Corporation, Somers, NY) software, 
was used for data analysis. Chi-square test was used for quali-
tative variables and Student’s t-test for quantitative variables. 
Fisher’s exact test was used when n , 5. Differences with a 
P value , 0.05 were considered statistically significant, and 
a P value between 0.05 and 0.10 was considered to indicate 
a tendency to significance.
Results
The Tables 1–4 and Figure 1 show a detailed description of 
the variables and the comparative statistical analyses for the 
whole population and the groups.
Gender distribution for the whole sample showed no clear 
predominance, although the percentage of males (56%) was 
higher than females (44%). When stratified by group, there 
was no gender difference in the group of cases, whereas in 
the group of controls there was a higher percentage of males 
(64%), which was not statistically significant (P = 0.400). 
Other authors have also reported that gender is not a risk 
factor for the disease.1,2
Most patients showed unilateral involvement (61%), with 
no left or right eye predominance (50% right [OD] and 50% 
left [OS], among unilateral). When stratified by group, this 
pattern did not change: 66% OS in unilateral controls and 
61% OD in unilateral cases. These results are consistent with 
those of other published series.1–4
There was no significant association between group with 
respect to: maternal race/ethnicity (P = 0.241), geographic 
origin, genetic or gestational alterations, child neurologic 
or systemic alterations, contralateral eye pathologies (when 
unilateral), gestation, delivery (P = 0.343), and parity. 
These data are in agreement with those of other published 
series.1,2
Mean maternal age at birth was: 33 ± 6.6 years for the 
whole group (n = 28), 35.4 ± 5.2 years in the group of controls 
(n = 10), and 31.3 ± 7.3 years in the group of cases (n = 14). 
These data suggest a tendency to significance (P = 0.1) for 
worse cosmetic prognosis in younger mothers of the cases. 
Maternal sociocultural level also showed a tendency to 
significance (P = 0.098) between groups. Neither of these 
two variables has previously been considered as a risk factor 
in the literature.1,2
In all patients, prenatal obstetric ultrasound was unremark-
able; diagnosis was therefore made at the time of birth (n = 34), 
Table 1 Chief complaint (N = 36)
Chief complaint Number of patients
Bilateral anophthalmia 4
OD anophthalmia 2
OD anophthalmia + OS microphthalmia 3
OS anophthalmia 3
OS anophthalmia + OD microphthalmia 1
Bilateral microphthalmia 6
OD microphthalmia 8
OS microphthalmia 9
Abbreviations: OD, right; OS, left.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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except in two patients with mild microphthalmia diagnosed 
several months after birth. Regarding diagnostic imaging tech-
niques, ocular ultrasound was used most frequently (n = 25), 
followed by MRI (n = 11) and CT scan (n = 8).
Karyotype test was performed in 13 patients, three of 
whom showed some minor genetic alterations with no sys-
temic or syndromic anomalies.
Cosmetic outcomes (Table 4) between cases and   controls 
were compared, grouping the four categories into two: 
  satisfactory outcome (good and very good) and unsatisfactory 
outcome (poor and very poor). This allowed a comparison 
of larger samples.
Discussion
Given the low prevalence of congenital anophthalmia and 
microphthalmia, which varies widely in reported series, the 
authors of this present paper believe that the sample size was 
adequate (n = 36 patients), in comparison with that of other 
studies: surgical series reported by Krastinova (n = 19) and 
Schittkowski (n = 13), and epidemiological series by Shaw 
(n = 100) and Forrester (n = 96).1,2,4,24
There was a statistically significant association in the 
group of controls with cataracts (P = 0.05) and inferior 
chorioretinal coloboma (P = 0.026). This circumstance 
could be explained by the fact that these focal ocular 
Table 3 Therapeutic management and complications
Variable Global (N) Number of controls Number of cases
Functional treatments  
(N = 36); P = 0.000
Cataract surgery + PFV (8) 8 0
Retina surgery (1) 1 0
External rehabilitation  
(N = 36)
External conformera (23)  
P = 0.003
1 22
Canthotomy (6) 0 6
Conjunctival sac reconstruction (6) 0 6
Tarsorraphy (10) 0 10
Internal rehabilitation  
(N = 36)
Enucleation (8) 0 8
Internal prosthesis (9)  
P = 0.006
0 9
Oral mucous graft (6) 0 6
Calvarial bone graft (2) 0 2
Dermafat graft (5) 0 5
Orbital expansion (3) 0 3
Complications Implant infection (N = 9): (2) 0 2
Internal prosthesis exposure (N = 9): (2) 0 2
Ptosis (N = 36): (10)  
P = 0.003
0 10
Notes: P-values are between groups. aWhen both eyes were affected, only the most severe was considered (being the most susceptible to further surgical intervention), 
except for one patient with OS anophthalmia and OD microphthalmia with superior eyelid agenesis and acceptable vision. This patient was considered as a “control” because 
surgical procedures were performed on his best eye (OD), including application of a modified external conformer (in this variable, n = 23 “cases”).
Abbreviations: OD, right; OS, left; PFV, persistent fetal vasculature.
Table 2 Main epidemiological characteristics and possible risk factors
Variable Global (N) Number of controls Number of cases
Maternal educational level  
(N = 28); P = 0.098
.12 years (16) 9 7
,12 years (12) 3 9
Associated ocular pathology  
(N = 36)
Cataract (3); P = 0.05 3 0
PFV (9); P = 0.267 5 4
Inferior coloboma (10); P = 0.026 7 3
Pathologic associations Family history (N = 31); P = 0.056 6 3
Systemic alterations  
(N = 36); P = 1.000
3 4
Neurologic alterations  
(N = 36); P = 1.000
1 3
Contralateral eye involvement  
(N = 22 unilateral); P = 0.544
2 1
Note: P-values are between groups.
Abbreviation: PFV, persistent fetal vasculature.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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defects may have useful visual acuity and they produce mild 
microphthalmia.
In contrast to the cases, family history showed a tendency 
to significance in the group of controls (P = 0.056). Isolated 
microphthalmia has no known hereditary pattern, whereas 
congenital cataract is considered a hereditary pathology and 
was predominantly found in the control group. Obviously, 
when microphthalmia or anophthalmia are associated to Fraser, 
Fryns, Waardenburg, or Matthew-Wood syndromes, patients 
present well known hereditary genetic anomalies.9–15
In this present study, no association with systemic or 
neurologic alterations or contralateral eye involvement (when 
unilateral) was found in the whole sample or in either of the 
two groups.
Ocular ultrasonography, which is noninvasive, readily 
available, and easy to perform, is useful in microphthalmia 
to assess axial length and intraocular conditions such as 
retinal detachment, posterior staphyloma, or retro-ocular 
cyst. Besides, it provides useful information in ocular growth 
follow-up.
CT and MRI are necessary to evaluate the presence of 
any ocular tissue in patients with clinical anophthalmia and 
the position and vascularization of orbital implants.20 MRI 
is preferable in these patients because it is radiation-free and 
offers higher spatial resolution of soft tissues. However, CT 
best depicts the osseous orbital cavity.
In general, the patients in this study showed satisfactory 
cosmetic outcome: 66.7% had good or very good orbital 
growth, and 75% had good or very good facial   symmetry. 
Better results for symmetry can be explained by the pres-
ence of bilateral involvement, where even with insuf-
ficient orbital growth, both sides of the face are similarly 
affected.
However, poor results were obtained for external con-
former mobility (poor or very poor in 100% of cases, n = 23) 
and internal implant mobility (poor or very poor in 100% 
of cases, n = 9). A search of the literature found no specific 
percentages with which to compare these surgical results. 
Only isolated techniques for orbital rehabilitation or general 
surgical complications were found.4–6,24,25
When stratified by group, the controls achieved better 
orbital development than the cases, both in the four semi-
quantitative categories (P = 0.042) and when grouped into 
two categories (satisfactory outcome = good and very good; 
unsatisfactory outcome = poor and very poor) (P = 0.011). 
The group of controls also showed better facial symmetry 
(P = 0.014 in the four categories and P = 0.062 in two).
Table 4 Cosmetic outcomes
Variable Global Number  
of controls
Number   
of cases
Orbital growth  
  (N = 36)  
  P = 0.042
Very good (N = 9) 6 3
Good (N = 15) 7 8
Poor (N = 8) 1 7
Very poor (N = 4) 0 4
Facial symmetry  
  (N = 36)  
  P = 0.014
Very good (N = 12) 9 3
Good (N = 15) 4 11
Poor (N = 7) 1 6
Very poor (N = 2) 0 2
External mobility  
  (N = 23)
Very good (N = 0) 0 0
Good (N = 0) 0 0
Poor (N = 15) 1 14
Very poor (N = 8) 0 8
Internal mobility  
  (N = 9)
Very good (N = 0) 0 0
Good (N = 0) 0 0
Poor (N = 5) 0 5
Very poor (N = 4) 0 4
Note: P-values are between groups.
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Figure 1 Diagnosis at baseline (n = 50 affected eyes).
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Surgical complications that commonly require further 
intervention include: cicatricial retraction of the conjunctival 
sac, exposure or extrusion of the internal implant, external 
conformer extrusion, infection, and obviously, insufficient 
orbital expansion.4,6,25 The complication rate was approxi-
mately 22% for infection and implant exposure/extrusion. 
Eyelid ptosis was found in 27.7% of the whole sample, all 
belonging to the group of cases (P = 0.003). It seems that the 
globe, even when microphthalmic, acts as a natural stimulus 
for orbital growth and preserves superior eyelid function. 
In contrast, external conformers are not always sufficient 
to achieve adequate superior and inferior conjunctival sac, 
and eyelid function is partially or totally abolished in some 
patients. Or, it may be that these patients had severe hypo-
plastic eyelid muscles (microblepharon) from baseline.
The present study suggests that natural stimulation of 
orbitofacial growth provided by a microphthalmic eye results 
in better outcome than artificial stimulation currently avail-
able with external and/or internal orbital conformers. These 
results are probably explained by the heterogeneous nature of 
the two groups, with higher associated pathology in the cases 
(micro-orbitism, microblepharon) and the baseline severity of 
the ocular disease itself. The possibility of other orbitofacial 
growth factors apart from the eye cannot be excluded and 
require further research.
Orbital rehabilitation in congenital anophthalmia and 
microphthalmia is a frustrating anatomical challenge for 
both parents and physicians. Every expansion technique has 
important limitations, and in some cases, despite several sur-
gery procedures, patients do not achieve appropriate cosmetic 
outcome. It is encouraging to see satisfactory cosmetic out-
comes in the cases (50% for orbital growth and 63% for facial 
symmetry) and the low rate of surgical complications.
The sample size was comparable with those of previous 
studies, especially the surgical series. However, larger sample 
sizes and longer follow-up periods are required in future studies. 
The results reported here allow us to persevere with the compli-
cated task of orbitofacial rehabilitation of these patients.
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